Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bexagliflozin. Always confirm against the full prescribing information.
100 interactions
Acarbose
Bexagliflozin may increase the hypoglycemic activities of Acarbose.
Level 2 evidence
Acebutolol
The therapeutic efficacy of Bexagliflozin can be increased when used in combination with Acebutolol.
Level 1 evidence
Acetylsalicylic acid
The risk or severity of hypoglycemia can be increased when Acetylsalicylic acid is combined with Bexagliflozin.
Level 1 evidence
Adenine
The metabolism of Bexagliflozin can be decreased when combined with Adenine.
Level 2 evidence
Alclometasone
The risk or severity of hyperglycemia can be increased when Alclometasone is combined with Bexagliflozin.
Level 1 evidence
Alogliptin
Bexagliflozin may increase the hypoglycemic activities of Alogliptin.
Level 2 evidence
Amcinonide
The risk or severity of hyperglycemia can be increased when Amcinonide is combined with Bexagliflozin.
Level 1 evidence
Aminosalicylic acid
Aminosalicylic acid may increase the hypoglycemic activities of Bexagliflozin.
Level 2 evidence
Amiodarone
The risk or severity of hypoglycemia can be increased when Amiodarone is combined with Bexagliflozin.
Level 2 evidence
Amitriptyline
Amitriptyline may decrease the hypoglycemic activities of Bexagliflozin.
Level 2 evidence
Amlodipine
The risk or severity of hypoglycemia can be increased when Amlodipine is combined with Bexagliflozin.
Level 2 evidence
Amoxapine
Amoxapine may decrease the hypoglycemic activities of Bexagliflozin.
Bexagliflozin has 347 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Bexagliflozin has 0 major, 313 moderate, and 34 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Bexagliflozin. Always confirm against the full prescribing information.